Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage.

Zheng L, Zhang Y, Hao S, Chen L, Sun Z, Yan C, Whitin JC, Jang T, Merchant M, McElhinney DB, Sylvester KG, Cohen HJ, Recht L, Yao X, Ling XB.

PLoS One. 2019 Oct 10;14(10):e0223558. doi: 10.1371/journal.pone.0223558. eCollection 2019.

2.

Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.

Thomas RP, Nagpal S, Iv M, Soltys SG, Bertrand S, Pelpola JS, Ball R, Yang J, Sundaram V, Lavezo J, Born D, Vogel H, Brown JM, Recht LD.

Clin Cancer Res. 2019 Sep 19. doi: 10.1158/1078-0432.CCR-19-1421. [Epub ahead of print]

PMID:
31537527
3.

Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making.

Iv M, Liu X, Lavezo J, Gentles AJ, Ghanem R, Lummus S, Born DE, Soltys SG, Nagpal S, Thomas R, Recht L, Fischbein N.

AJNR Am J Neuroradiol. 2019 Oct;40(10):1649-1657. doi: 10.3174/ajnr.A6211. Epub 2019 Sep 12.

PMID:
31515215
4.

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.

Miller SE, Tummers WS, Teraphongphom N, van den Berg NS, Hasan A, Ertsey RD, Nagpal S, Recht LD, Plowey ED, Vogel H, Harsh GR, Grant GA, Li GH, Rosenthal EL.

J Neurooncol. 2018 Aug;139(1):135-143. doi: 10.1007/s11060-018-2854-0. Epub 2018 Apr 6.

5.

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.

Hyman DM, Rizvi N, Natale R, Armstrong DK, Birrer M, Recht L, Dotan E, Makker V, Kaley T, Kuruvilla D, Gribbin M, McDevitt J, Lai DW, Dar M.

Clin Cancer Res. 2018 Jun 15;24(12):2749-2757. doi: 10.1158/1078-0432.CCR-17-1775. Epub 2018 Mar 20.

6.

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH.

Lancet Oncol. 2017 Dec;18(12):e709-e710. doi: 10.1016/S1470-2045(17)30856-2. No abstract available.

PMID:
29208433
7.

A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.

Corbin Z, Spielman D, Recht L.

Curr Oncol Rep. 2017 Nov 2;19(12):84. doi: 10.1007/s11912-017-0637-y. Review.

PMID:
29098465
8.

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators.

Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.

9.

Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center.

Porter JB, Rosenthal EL, Winget M, Smith AS, Seshadri SB, Vetteth Y, Kiamanesh EF, Badwe A, Advani RH, Buyyounouski MK, Coutre S, Dirbas F, Divi V, Dorigo O, Ganjoo KN, Johnston LJ, Recht LD, Shrager JB, Skinner EC, Swetter SM, Visser BC, Blayney DW.

J Oncol Pract. 2017 Aug;13(8):e673-e682. doi: 10.1200/JOP.2017.021139. Epub 2017 Jul 20.

10.

Optimizing bevacizumab dosing in glioblastoma: less is more.

Ajlan A, Thomas P, Albakr A, Nagpal S, Recht L.

J Neurooncol. 2017 Oct;135(1):99-105. doi: 10.1007/s11060-017-2553-2. Epub 2017 Jun 30.

PMID:
28667595
11.

The Wheel and the Ladder: Freudian and Loewaldian Accounts of Individuation.

Recht L.

Psychoanal Rev. 2017 Jun;104(3):313-350. doi: 10.1521/prev.2017.104.3.313. Review.

PMID:
28613132
12.

Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.

Pollom EL, Fujimoto D, Wynne J, Seiger K, Modlin LA, Jacobs LR, Azoulay M, von Eyben R, Tupper L, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR, Harsh GR, Harraher C, Nagpal S, Thomas RP, Recht LD, Choi CYH, Soltys SG.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):123-130. doi: 10.1016/j.ijrobp.2017.01.242. Epub 2017 Feb 7.

13.

The Promise of Targeting Macrophages in Cancer Therapy.

Brown JM, Recht L, Strober S.

Clin Cancer Res. 2017 Jul 1;23(13):3241-3250. doi: 10.1158/1078-0432.CCR-16-3122. Epub 2017 Mar 24. Review.

14.

Bevacizumab for Treatment-Refractory Pain Control in Neurofibromatosis Patients.

Linda XW, Recht LD.

Cureus. 2016 Dec 18;8(12):e933. doi: 10.7759/cureus.933.

15.

SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.

Deng L, Stafford JH, Liu SC, Chernikova SB, Merchant M, Recht L, Martin Brown J.

Neoplasia. 2017 Jan;19(1):1-7. doi: 10.1016/j.neo.2016.11.010. Epub 2016 Dec 7.

16.

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker Analyses.

Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, Brandes AA, Pineda E, Mikkelsen T, Chinot OL, Balana C, Macdonald DR, Westphal M, Hopkins K, Weller M, Bais C, Sandmann T, Bruey JM, Koeppen H, Liu B, Verret W, Phan SC, Shames DS.

J Clin Oncol. 2017 Jan 20;35(3):343-351. doi: 10.1200/JCO.2015.64.7685. Epub 2016 Dec 5.

PMID:
27918718
17.

Response of metastatic glioma to vemurafenib.

Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP.

Neurooncol Pract. 2016 Dec;3(4):268-271. doi: 10.1093/nop/npv054. Epub 2015 Nov 22.

18.

A Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme.

Azoulay M, Ho CK, Fujimoto DK, Modlin LA, Gibbs IC, Hancock SL, Li G, Chang SD, Adler JR Jr, Harsh GR, Nagpal S, Thomas R, Recht L, Choi CY, Soltys SG.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E131-E132. doi: 10.1016/j.ijrobp.2016.06.921. No abstract available.

PMID:
27673859
19.

Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.

Iagaru A, Mosci C, Mittra E, Zaharchuk G, Fischbein N, Harsh G, Li G, Nagpal S, Recht L, Gambhir SS.

Radiology. 2016 Jul;280(1):328. doi: 10.1148/radiol.2016164020. No abstract available.

PMID:
27322985
20.

Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.

Park JM, Spielman DM, Josan S, Jang T, Merchant M, Hurd RE, Mayer D, Recht LD.

NMR Biomed. 2016 May;29(5):650-9. doi: 10.1002/nbm.3509. Epub 2016 Mar 14.

21.

Central Nervous System Cancers, Version 1.2015.

Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Lawson R, Loeffler JS, Lovely MP, Moots PL, Mrugala MM, Newton HB, Parney I, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Weiss S, Wen PY, McMillian N, Engh AM.

J Natl Compr Canc Netw. 2015 Oct;13(10):1191-202.

PMID:
26483059
22.

Inflammatory Pseudotumors of the Skull Base: Meta-Analysis.

Alyono JC, Shi Y, Berry GJ, Recht LD, Harsh GR 4th, Jackler RK, Corrales CE.

Otol Neurotol. 2015 Sep;36(8):1432-8. doi: 10.1097/MAO.0000000000000818.

PMID:
26164448
23.

Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis.

Tan Z, Liu R, Zheng L, Hao S, Fu C, Li Z, Deng X, Jang T, Merchant M, Whitin JC, Guo M, Cohen HJ, Recht L, Ling XB.

Methods. 2015 Jul 15;83:36-43. doi: 10.1016/j.ymeth.2015.05.004. Epub 2015 May 14.

PMID:
25982164
24.

Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.

Iagaru A, Mosci C, Mittra E, Zaharchuk G, Fischbein N, Harsh G, Li G, Nagpal S, Recht L, Gambhir SS.

Radiology. 2015 Nov;277(2):497-506. doi: 10.1148/radiol.2015141550. Epub 2015 May 12. Erratum in: Radiology. 2016 Jul;280(1):328.

PMID:
25965900
25.

Volumetric spiral chemical shift imaging of hyperpolarized [2-(13) c]pyruvate in a rat c6 glioma model.

Park JM, Josan S, Jang T, Merchant M, Watkins R, Hurd RE, Recht LD, Mayer D, Spielman DM.

Magn Reson Med. 2016 Mar;75(3):973-84. doi: 10.1002/mrm.25766. Epub 2015 May 6.

26.

Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.

Nagpal S, Recht CK, Bertrand S, Thomas RP, Ajlan A, Pena J, Gershon M, Coffey G, Kunz PL, Li G, Recht LD.

J Neurooncol. 2015 Jun;123(2):277-82. doi: 10.1007/s11060-015-1795-0. Epub 2015 May 3.

27.

Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain.

Andre JB, Nagpal S, Hippe DS, Ravanpay AC, Schmiedeskamp H, Bammer R, Palagallo GJ, Recht L, Zaharchuk G.

Neuroradiol J. 2015 Apr;28(2):112-9. doi: 10.1177/1971400915576641. Epub 2015 Apr 28.

28.

γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.

Bui TT, Nitta RT, Kahn SA, Razavi SM, Agarwal M, Aujla P, Gholamin S, Recht L, Li G.

BMC Cancer. 2015 Apr 7;15:225. doi: 10.1186/s12885-015-1232-y.

29.

Treatment options for optic pathway gliomas.

Thomas RP, Gibbs IC, Xu LW, Recht L.

Curr Treat Options Neurol. 2015 Feb;17(2):333. doi: 10.1007/s11940-014-0333-2.

PMID:
25619537
30.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH.

Neuro Oncol. 2015 Jun;17(6):854-61. doi: 10.1093/neuonc/nou348. Epub 2015 Jan 13.

31.

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Moots PL, Mrugala MM, Newton HB, Raizer JJ, Recht L, Shonka N, Shrieve DC, Sills AK Jr, Swinnen LJ, Tran D, Tran N, Vrionis FD, Wen PY, McMillian NR, Ho M.

J Natl Compr Canc Netw. 2014 Nov;12(11):1517-23.

32.

Metabolite profiling and integrative modeling reveal metabolic constraints for carbon partitioning under nitrogen starvation in the green algae Haematococcus pluvialis.

Recht L, Töpfer N, Batushansky A, Sikron N, Gibon Y, Fait A, Nikoloski Z, Boussiba S, Zarka A.

J Biol Chem. 2014 Oct 31;289(44):30387-403. doi: 10.1074/jbc.M114.555144. Epub 2014 Sep 2.

33.

Supratentorial low-grade diffuse astrocytoma: medical management.

Ajlan A, Recht L.

Semin Oncol. 2014 Aug;41(4):446-457. doi: 10.1053/j.seminoncol.2014.06.013. Epub 2014 Jul 1. Review.

PMID:
25173138
34.

A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

Chamberlain MC, Grimm S, Phuphanich S, Recht L, Zhu JZ, Kim L, Rosenfeld S, Fadul CE; Brain Tumor Investigational Consortium (BTIC).

J Neurooncol. 2014 Jun;118(2):335-343. doi: 10.1007/s11060-014-1437-y. Epub 2014 Apr 17.

PMID:
24740196
35.

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.

Walters MJ, Ebsworth K, Berahovich RD, Penfold ME, Liu SC, Al Omran R, Kioi M, Chernikova SB, Tseng D, Mulkearns-Hubert EE, Sinyuk M, Ransohoff RM, Lathia JD, Karamchandani J, Kohrt HE, Zhang P, Powers JP, Jaen JC, Schall TJ, Merchant M, Recht L, Brown JM.

Br J Cancer. 2014 Mar 4;110(5):1179-88. doi: 10.1038/bjc.2013.830. Epub 2014 Jan 14.

36.

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.

Liu SC, Alomran R, Chernikova SB, Lartey F, Stafford J, Jang T, Merchant M, Zboralski D, Zöllner S, Kruschinski A, Klussmann S, Recht L, Brown JM.

Neuro Oncol. 2014 Jan;16(1):21-8. doi: 10.1093/neuonc/not149. Epub 2013 Dec 10.

37.

Central nervous system cancers.

Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Maor MH, Moots PL, Morrison T, Mrugala MM, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Tran D, Tran N, Vrionis FD, Wen PY, McMillian N, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1114-51.

38.

Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.

Lin CY, Siow TY, Lin MH, Hsu YH, Tung YY, Jang T, Recht L, Chang C.

Angiogenesis. 2013 Oct;16(4):785-93. doi: 10.1007/s10456-013-9355-8. Epub 2013 Jun 5.

PMID:
23736837
39.

Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI.

Schmiedeskamp H, Andre JB, Straka M, Christen T, Nagpal S, Recht L, Thomas RP, Zaharchuk G, Bammer R.

J Cereb Blood Flow Metab. 2013 May;33(5):732-43. doi: 10.1038/jcbfm.2013.10. Epub 2013 Mar 6.

40.

Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy.

Recht L, Mechtler LL, Wong ET, O'Connor PC, Rodda BE.

J Clin Oncol. 2013 Mar 20;31(9):1182-7. doi: 10.1200/JCO.2012.43.9455. Epub 2013 Feb 4.

PMID:
23382470
41.

Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging.

Park JM, Recht LD, Josan S, Merchant M, Jang T, Yen YF, Hurd RE, Spielman DM, Mayer D.

Neuro Oncol. 2013 Apr;15(4):433-41. doi: 10.1093/neuonc/nos319. Epub 2013 Jan 17.

42.

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.

Thomas RP, Recht L, Nagpal S.

Clin Pharmacol. 2013;5:1-9. doi: 10.2147/CPAA.S26586. Epub 2012 Dec 27.

43.

Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.

Yamaguchi Y, Shao Z, Sharif S, Du XY, Myles T, Merchant M, Harsh G, Glantz M, Recht L, Morser J, Leung LL.

J Biol Chem. 2013 Feb 1;288(5):3097-111. doi: 10.1074/jbc.M112.362954. Epub 2012 Nov 30.

44.

Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.

Whitin JC, Jang T, Merchant M, Yu TT, Lau K, Recht B, Cohen HJ, Recht L.

PLoS One. 2012;7(11):e49724. doi: 10.1371/journal.pone.0049724. Epub 2012 Nov 19.

45.

Patterns of carbohydrate and fatty acid changes under nitrogen starvation in the microalgae Haematococcus pluvialis and Nannochloropsis sp.

Recht L, Zarka A, Boussiba S.

Appl Microbiol Biotechnol. 2012 Jun;94(6):1495-503. doi: 10.1007/s00253-012-3940-4. Epub 2012 Feb 25.

PMID:
22361859
46.

Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-(13)C]pyruvate.

Park JM, Josan S, Jang T, Merchant M, Yen YF, Hurd RE, Recht L, Spielman DM, Mayer D.

Magn Reson Med. 2012 Dec;68(6):1886-93. doi: 10.1002/mrm.24181. Epub 2012 Feb 14.

47.

Bevacizumab improves quality of life in patients with recurrent glioblastoma.

Nagpal S, Harsh G, Recht L.

Chemother Res Pract. 2011;2011:602812. doi: 10.1155/2011/602812. Epub 2011 Oct 2.

48.

Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.

Zhao L, Yamaguchi Y, Sharif S, Du XY, Song JJ, Lee DM, Recht LD, Robinson WH, Morser J, Leung LL.

J Biol Chem. 2011 Nov 11;286(45):39520-7. doi: 10.1074/jbc.M111.258954. Epub 2011 Sep 19.

49.

Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme.

Chagovetz AA, Jensen RL, Recht L, Glantz M, Chagovetz AM.

J Neurooncol. 2011 Dec;105(3):499-506. doi: 10.1007/s11060-011-0630-5. Epub 2011 Jul 1.

PMID:
21720810
50.

Treatment and prophylaxis of hematologic malignancy in the central nervous system.

Nagpal S, Recht L.

Curr Treat Options Neurol. 2011 Aug;13(4):400-12. doi: 10.1007/s11940-011-0128-7.

PMID:
21484261

Supplemental Content

Support Center